Safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial

Jona V Caparas, Jian-Ping Hu, Jona V Caparas, Jian-Ping Hu

Abstract

Background: According to the 2011 Infusion Nursing Standards of Practice, the low pH of intravenous vancomycin requires that it be administered through a central line. However, a careful review of the literature and a retrospective analysis of the experience at New York Hospital Queens (NYHQ) did not support the position of the Standards.

Purpose: A prospective, controlled, randomized clinical trial was conducted to determine if intravenous vancomycin could be safely administered through a novel midline catheter (POWERWAND®, Access Scientific, San Diego, CA).

Methods: Patients scheduled to receive short-term (<6 days) intravenous vancomycin were randomly assigned to receive treatment through either a peripherally inserted central catheter (PICC) or the midline study device. Complications and the costs of insertion were recorded.

Results: The two groups did not differ significantly with respect to total complications (17.9% with PICCs vs. 19.9% with the midline), phlebitis (0% vs. 0%) or thrombosis (0% vs. 0%). One suspected catheter-associated bloodstream infection did occur in the PICC group. Insertion costs were $90.00 less per insertion in the midline group.

Conclusions: Short-term intravenous vancomycin can be safely and cost-efficiently administered in the deep vessels of the upper arm using the midline study device.

Conflict of interest statement

Conflict of interest: The authors disclose no conflict of interest.

References

    1. O'Grady N.P., Alexander M., Burns L.S. et al. CDC guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011; 39(4): S3, S5.
    1. Stoker R. Accelerated Seldinger technique. Managing Inf Cont. 2009; March: 32–35.
    1. Dawson R.B., Moreau N.L. Midlines—an essential tool in CLABSI reduction. Infect Control Today. 2013; 17(3): 42–45.
    1. Warrington W.G., Penoyer D.A., Kamps T. et al. Outcomes of using a modified Seldinger technique for long term intravenous therapy in hospitalized patients with difficult venous access. JAVA. 2012; 17(1): 24–31.
    1. Caparas J. Staff Education/Training Aids Implementation of Advanced Midline Catheter. Scientific Poster, presented at: INS Annual Convention & Industrial Exhibition; May 2013.
    1. Gorski L.A., Eddins J., Hadaway L. et al. Infusion nursing standards of practice (revised 2011). JIN. 2013; 34(1S): S37–S38.
    1. McGoldrick M. Infection prevention and control. In: Alexander M., Corrigan A., Gorski L. et al. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St. Louis, MO: Saunders/Elsevier; 2010: 204–228.
    1. Bullock-Corkhill M. Central vascular access device access and insertion. In: Alexander M., Corrigan A., Gorski L. et al. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St. Louis, MO: Saunders/Elsevier; 2010: 480–494.
    1. Cheung E., Baerlocher M.O., Asch M., Myers A. Venous access: a practical review for 2009. Can Fam Physician. 2009; 55(5): 494–496.
    1. Hadaway L. Infusion therapy equipment. In: Alexander M., Corrigan A., Gorski L. et al. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St. Louis, MO: Saunders/Elsevier; 2010: 391–436.
    1. Perruca R. Peripheral vascular access. In: Alexander M., Corrigan A., Gorski L. et al. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St. Louis, MO: Saunders/Elsevier; 2010: 456–479.
    1. Mirtallo J, Canada T, Johnson D, et al; American Society for Parenteral and Enteral Nutrition. Safe practices for parenteral nutrition: practice guidelines for safe practice for parenteral nutrition. J Parenter Enteral Nutr. 2004; 28(6): S39–S70.
    1. Isaacs J.W., Millikan W.J., Stackhouse J., Hersh T., Rudman D. Parenteral nutrition of adults with a 900 milliosmolar solution via peripheral veins. Am J Clin Nutr. 1977; 30(4): 552–559.
    1. Pettit J., Wyckoff M. Peripherally Inserted Central Catheters: Guidelines for Practice. 2nd ed. Glenview, IL: National Association of Neonatal Nurses: 2007.
    1. Gura K.M. Is there still a role for peripheral parenteral nutrition? Nutr Clin Pract. 2009; 24(6): 709–717.
    1. Krzywda E.A., Meyer D. Parenteral nutrition. In: Alexander M., Corrigan A., Gorski L. et al. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St. Louis, MO: Saunders/Elsevier; 2010: 316–350.
    1. Hayden B.K., Goodman M. Chemotherapy: principles of administration. In: Cancer Nursing: Principles and Practice. 6th ed. Boston, MA: Jones & Bartlett; 2005: 352–412.
    1. Oncology Nursing Society. Chemotherapy and Biotherapy: Guidelines and Recommendations for Practice. 2nd ed. Pittsburgh, PA: ONS; 2005.
    1. Bishop L., Dougherty L., Bodenham A. et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007; 29(4): 261–278.
    1. Fonkalsrud E.W., Murphy J., Smith FG Jr.. Effect of pH in glucose infusions on development of thrombophlebitis. J Surg Res. 1968; 8(11): 539–543.
    1. Lewis G.B.H., Hecker J.F. Infusion thrombophlebitis. Br J Anaesth. 1985; 57(2): 220–233.
    1. Tagalakis V., Kahn S.R., Libman M., Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med. 2002; 113(2): 146–151.
    1. Campbell L. I.v.-related phlebitis, complications and length of hospital stay: 1. Br J Nurs. 1998; 7(21): 1304–1306, 1308-1312.
    1. Harrigan C.A. A cost-effective guide for the prevention of chemical phlebitis caused by the pH of the pharmaceutical agent. NITA. 1984; 7(6): 478–482.
    1. Maki D.G., Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med. 1991; 114(10): 845–854.
    1. Monreal M., Quilez F., Rey-Joly C. et al. Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest. 1999; 115(6): 1576–1580.
    1. Cicolini G., Bonghi A.P., Di Labio L., Di Mascio R. Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observational study. J Adv Nurs. 2009; 65(6): 1268–1273.
    1. Tripathi S., Kaushik V., Singh V. Peripheral IVs: factors affecting complications and patency—a randomized controlled trial. J Infus Nurs. 2008; 31(3): 182–188.
    1. Hawes M.L. A proactive approach to combating venous depletion in the hospital setting. JIN. 2007; 30(1): 33–44.
    1. Kirschner R. Contrast media—phlebitis implications. US Radiology. 2010; 2(1): 27–30.
    1. Kokotis K. Preventing chemical phlebitis. Nursing. 1998; 28(11): 41–46.
    1. Roszell S., Jones C. Intravenous administration issues. JIN. 2010; 33(2): 112–118.
    1. Jones E.R. Relationship between pH of intravenous medications and phlebitis: an experimental study. NITA. 1982; 5(4): 273–276.
    1. Lanbeck P., Odenholt I., Paulsen O. Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis. 2002; 34(7): 512–519.
    1. Mowry J.L., Hartman L.S. Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin. West J Nurs Res. 2011; 33(3): 457–471.
    1. Balliad P., Peterson S. Midline Catheter Reduces Infiltrations for Coronary Artery Bypass Graft Patients. Scientific Poster, presented at: INS Annual Convention & Industrial Exhibition; May 2013.
    1. LaRue G.D., Peterson M. The impact of dilution on intravenous therapy. JIN. 2011; 34(2): 117–123.
    1. Bohm N.M., Wong J.G. Bullous dermatosis associated with vancomycin extravasation. Am J Med Sci. 2012; 343(2): 117–119.
    1. Hoelen D.W.M., Tjan D.H.T., van Vugt R., van der Meer Y.G., van Zanten A.R. Severe local vancomycin induced skin necrosis. Br J Clin Pharmacol. 2007; 64(4): 553–554.
    1. Periard D., Monney P., Waeber G. et al. Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy. J Thromb Haemost. 2008; 6(8): 1281–1288.
    1. Bonizzoli M., Batacchi S., Cianchi G. et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med. 2011; 37(2): 284–289.
    1. Prandoni P. Prophylaxis of catheter-related thrombosis in cancer patients. Lancet. 2009; 373(9663): 523–524.
    1. Chopra V., Flanders S.A., Saint S. The problem with peripherally inserted central catheters. JAMA. 2012; 308(15): 1527–1528.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner